טוען...
Induction of kinase suppressor of RAS-1(KSR-1) gene by1, α25-dihydroxyvitamin D(3) in human leukemia HL60 cells through a vitamin D response element in the 5′-flanking region
Differentiation therapy is being developed as an additional therapeutic option for the treatment of several forms of cancer, including myeloid leukemia. In model systems, the physiologically active form of vitamin D, 1, α25-dihydroxyvitamin D(3) (1,25D), induces monocytic differentiation of human my...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2843694/ https://ncbi.nlm.nih.gov/pubmed/16732322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1209697 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|